NextGenMicrofluidics was featured in the new BNN QUARTERLY (December 2022) with two articles about MIH. One article introduces MIH as a new BioNanoNet Association member (pages 32-33) and the other reports about the COMPAMED 2022.
NextGenMicrofluidics was featured in the new BNN QUARTERLY (December 2022) with two articles about MIH. One article introduces MIH as a new BioNanoNet Association member (pages 32-33) and the other reports about the COMPAMED 2022.
BioCHIP Berlin is an annual event focuses on technologies and applications of microfluidics in all related sectors. Demonstrate expertise, see device up and running, and establish new contacts, the show floor will provide companies engaged in development on/and the use of microsystems to share and discuss their most recent findings and understandings of microfluidic platforms, fabrication techniques, system integration and emerging applications for life sciences.
NextGenMicrofluidics and Microfluidics Innovation Hub (MIH) will participate at the BioCHIPS Berlin this year.
More information coming soon.
NextGenMicrofluidics was featured in the new BNN QUARTERLY (December 2022) with two articles about MIH. One article introduces MIH as a new BioNanoNet Association member (pages 32-33) and the other reports about the COMPAMED 2022.
The 22nd edition of the Trends in Nanotechnology International Conference (TNT2022) is being launched following the overwhelming success of earlier Nanotechnology Conferences. TNT2022 will take place in Tirana (Albania) for the 2nd year in a row in particular to launch a new conference series denominated nano Balkan from 3-7 October.
This high-level scientific meeting TNT series aims to present a broad range of current research in Nanoscience and Nanotechnology as well as related policies or other kind of initiatives such as nanoAlb.
Catch the presentation from Goerge Tsekenis from BRFAA – Biomedical Research Foundation Academy Of Athens on 𝐍𝐞𝐱𝐭𝐆𝐞𝐧𝐌𝐢𝐜𝐫𝐨𝐟𝐥𝐮𝐢𝐝𝐢𝐜𝐬: 𝐥𝐨𝐰-𝐜𝐨𝐬𝐭. 𝐦𝐨𝐝𝐮𝐥𝐚𝐫 𝐋𝐚𝐛-𝐨𝐧-𝐚-𝐂𝐚𝐫𝐭𝐫𝐢𝐝𝐠𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐟𝐨𝐫 𝐩𝐮𝐛𝐥𝐢𝐜 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐟𝐨𝐨𝐝 𝐬𝐚𝐟𝐞𝐭𝐲 𝐦𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠.
The MIH webinar series continues with a group of powerhouse experts presenting a topic that’s at the core of what we do at NextGenMicrofluidics. If you’re curious about why we say ‘We Get Microfluidics Rolling’, join us on October 13, Thursday at 15:00 to 16:30 CEST and listen to experts from Joanneum Research, Temicon, Micronit, Inmold and micro resist technology talk about the Advantages of Roll-to-roll Replication in Microfluidics.
The webinar is moderated by Microfluidics Innovation Hub General Manager Ronald Tingl and features the following presenters:
Anja Haase, Senior Scientist @ JOANNEUM RESEARCH Forschungsgesellschaft mbH
Jan Kafka, Chief Executive Officer @ Inmold A/S
André Bleise, Director Global Sales & Marketing @ Temicon GmbH
Alvaro Conde, Senior RD Scientist @ Micronit b.v.
The webinar will cover a range of topics on:
We can’t wait to let you know more about our roll-to-roll technologies for high-throughput manufacturing and how they can revolutionize your microfluidic device production.
PRESENTER: Dr. Jörg Nestler
Dr. Jörg Nestler has more than 15 years of experience in lab-on-a-chip development. He is the Founder and Managing Director of BiFlow Systems GmbH (Germany), which was founded in 2011 and aims to make complex diagnostics accessible to everyone at any time.
What topics will be covered in the webinar:
The biomedical engineering community will come together again in the heart of the Alps. Innsbruck with its unique combination of urban flair and impressive mountain scenery will provide an inspiring atmosphere to meet colleagues and friends, exchange scientific ideas, discuss current trends, initiate new research and make new contacts.
BNN encourages NextGenMicrofluidics beneficiaries and all interested parties to join our focus session “Nanotechnologies for Safe & Sustainable Biomedical Applications”.
Chairs: Andreas Falk, Susanne Resch, and Clemens Wolf, BioNanoNet Forschungsgesellschaft mbH (BNN), Austria
Dr. George Tsekenis from Biomedical Research Foundation of the Academy of Athens is going to give a presentation titled “NextGenMicrofluidics: low-cost, high-throughput manufacturing approaches for the development of microfluidics-based molecular diagnostics devices” during this focus session” on 28 September 2022 in Innsbruck, Austria.
NextGenMicrofluidics: low-cost, high-throughput manufacturing approaches for the development of microfluidics-based molecular diagnostics devices (Zena Chakim, Dimitris G. Karadimas, Jenny Graunitz, Joerg Nestler, Claude Leiner, Martin Smolka, Anja Haase, Jan Hesse, Richard Benauer, Andreas Flanschger, Andreas Mader, Wilfried Weigel, Nastasia Okulova, Jan Kafka, Conor O’Sullivan, Mirko Lohse, Janine Brommert, Christoph Stöver, Goran Bijelic, George Tsekenis)
The COVID-19 pandemic has highlighted the importance of population-scale screening to identify infected and often asymptomatic individuals, making the need for low-cost and reliable tests that can be widely-implemented even more pressing.
To address this need, and within the context of the H2020 NextGenMicrofluidics project, we have focused on the development of a microfluidic-based Lab-on-a-Chip (LoC), for the multiplexed detection of SARS-CoV-2 as well as Influenza A (both H1N1 and H3N2), combining a roll-to-roll (R2R) fabricated sensor foil with an injection-molded cartridge. Detection of viral genetic material relies on the Linear-after-the-Amplification (LATE) PCR protocol, while their detection is achieved through hybridization with a virus- and strain- specific microarray of probes, spotted onto an appropriately-functionalized polymer foil. The latter also serves as a waveguiding element, where a sensitive TIRF (total internal reflection fluorescence) readout is realised. Integration of the probe-spotted foil with a disposable microfluidic cartridge, consisting of several reservoirs for reagents as well as a capillary chamber for viral RNA amplification by means of convective PCR (cPCR), permits further reductions in the LoC footprint to be attained. Finally, liquids are moved within the cartridge by integrated electrochemical micropump, making PCB-based fluidic actuation obsolete.
Herein, the sensitive and selective detection of viral genetic material in real patient samples with the use of the novel LoC is demonstrated, while the challenges faced upon integrating the individual and highly-heterogeneous components of the molecular diagnostics assay are also discussed.
The proposed microfluidic-based LoC addresses the current global demand for sustainable and efficient processes in the diagnostics field as it enables high-throughput, cost-effective manufacturing, while the high degree of process parallelisation accomplished renders it suitable for the test quantities needed for mass screening and viral strain discrimination.
